Skip to contentB
Bausch Health Companies Inc.
B
BHCBausch Health Companies Inc. Q1 2018 · 10-Q
Revenue$2.00B$2.00B−5.4% vs Q1 2017 Net Income-$2.58B-$2.58BN/M vs Q1 2017 EPS Diluted-$7.36-$7.36N/M vs Q1 2017 Operating Income-$2,281,000,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
Free Cash Flowderived$405,000,000−55.8% Margins · derivedOperating margin-114.3%−124.3 pt vs Q1 2017
Net margin-129.3%−159.1 pt vs Q1 2017
ended Mar 31, 2018 · filed May 8, 2018 · 38 d after period end